ArchivesMagazine - 29 Jun 2023Drug companies under the spotlight after breakthrough with new weight-loss treatment Several pharmaceutical groups are trying to muscle in on a potentially lucrative market 29 June 2023|News|by Martin Gamble Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < How to get exposure to the best UK property assets in one go CAB Payments IPO could be the trigger to revive UK stock market flotations > Issue: 29 Jun 2023 - Page 7 | Contents Next: CAB Payments IPO could be the trigger to revive UK stock market flotations Previous: How to get exposure to the best UK property assets in one go Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Martin Gamble Issue Contents Case study How I invest: in my thirties and looking for undervalued growth opportunities Editor's View The reason why Frasers wants to own stakes in so many retailers Feature Investing for children: How to give them a head start in life Revealed: the companies which could join the exodus from the UK market Investing in ‘under-owned, underappreciated and undervalued’ emerging markets: 30 years of change Great Ideas Buy shares in Shell: it has a big plan to catch up with US rivals How to get exposure to the best UK property assets in one go Despite strong gains Ten Entertainment shares remain too cheap Investment Trusts Is this an opportune moment to pounce on private equity trusts? News The UK stock market is starting to look increasingly lopsided Drug companies under the spotlight after breakthrough with new weight-loss treatment CAB Payments IPO could be the trigger to revive UK stock market flotations Why the market was spooked by the Bank of England’s super-sized rate hike Fidelity China Special Situations shares hit after China reopening stutters Carnival shares have soared this year but it’s become a rockier ride Personal Finance How to use your children to cut your capital gains tax bill Russ Mould Why real interest rates matter for the performance of shares Under The Bonnet Salesforce has made investors rich over the years: are the shares worth buying today? Week Ahead Investors hope Jet2 results on 6 July will trigger a new share price rally Bud Light backlash set to boost Constellation Brands’ earnings
